A Clinical Study to Evaluate the Efficacy of Siddha Medicines in Bronchial Asthma
- Conditions
- Health Condition 1: J452- Mild intermittent asthmaHealth Condition 2: J453- Mild persistent asthmaHealth Condition 3: J454- Moderate persistent asthma
- Registration Number
- CTRI/2024/03/064944
- Lead Sponsor
- Central Council for Research in Siddha, Ministry of Ayush, Govt. of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
1. Symptoms of dry cough, recurrent attacks of dyspnoea, hoarseness of voice, tightness of chest, profuse sweating, and wheezing
2. Asthmatic attack due to seasonal changes and allergens
3. Willing to take radiological investigation and provide blood samples for lab investigation.
4. FEV1 with 50-80%
1. Asthma associated with COPD
2. Unstable bronchial asthma or status asthmaticus.
3. Asthma exacerbation during the past month.
4. COVID 19 Positive patients (on the time of recruitment).
5. Tuberculosis, Pneumonia, and Bronchogenic carcinoma
6. Cardiac, Liver and Renal Diseases.
7. Participation in another clinical trial within the preceding 90 days of the study starts.
8. Pregnant and lactating women.
9. Subjects with a continuing history of Alcohol, Smoking or Drug Abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method